In today’s pharmaceutical market, innovative new treatments with the potential to improve patients’ lives face unprecedented obstacles, including greater complexity and cost, more stringent evidence requirements to secure patient access beyond regulatory approval, a greater diversity of stakeholders and decision-makers and competition for share of voice.
Strategic, early medical affairs engagement can be the difference between a successful market entry and getting lost in the noise. Join this webinar for an insightful discussion with industry experts as they delve into the art and science of early medical affairs engagement, even when faced with limited resources.
In this webinar, the attendees will discover how small and mid-sized (SMID) companies can leverage thoughtful medical affairs planning and prioritization to drive significant impact and raise asset valuation on their journey to commercialization, including:
- Effective Prioritization on a Budget: How to prioritize tactics that deliver maximum value and ensure each investment enhances early medical affairs efforts and sets the stage for future success
- Navigating a Competitive Market: Strategies for driving company and scientific awareness in a crowded market, with an eye toward how to position the company and products effectively to stand out from the competition
- Real-World Examples and Expert Advice: Case studies and key learnings from industry experts who have been there, understand the challenges faced by SMID companies and can offer actionable advice and best practices
Benefit from the experiences of expert speakers who have successfully navigated the complexities of early market engagement.
Register for this webinar today to learn how small and mid-sized companies can effectively prioritize and leverage medical affairs strategies to enhance asset valuation and navigate competition.
Speakers
Anshu Sawhney, Vice President, Syneos One Medical Affairs, Syneos Health
Anshu Sawhney is Vice President and Global Medical Affairs Leader at Syneos Health and is focused on helping small-to medium-sized biopharma companies successfully transition from a clinical to commercial organization often launching their first asset. She has nearly 20 years of experience in the biopharmaceutical industry, spanning medical affairs, marketing and clinical pharmacy.
Anshu joined Syneos Health in 2020 after serving as a leader at Genentech in the immunology and pulmonary franchises. She also has extensive management consulting experience across various therapeutic areas including oncology, immunology, respiratory, dermatology and rare disease.
Before entering the industry, Anshu was a Clinical Pharmacist at leading institutions such as MD Anderson and Mount Sinai Medical Center. She holds a Doctorate of Pharmacy from the University of Texas at Austin and an MBA from the University of Southern California.
Message Presenter
Dr. Diego Grauman, MD, VP, Senior Medical Affairs Lead, Syneos Health
Dr. Diego Grauman brings over 30 years of healthcare experience. He practiced 12 years as a Radiation Oncologist, and then he has occupied positions of increasing responsibility within the pharma and biotech industry. He held numerous leadership roles at J&J, Novartis, Roche and Oncopeptides.
Diego has global, regional and country experience and has worked and lived in six countries through his career. Before joining Syneos Health as a Medical Lead, Dr. Grauman was the Executive Director of Medical Affairs at Oncopeptides, a Swedish global biotech with offices in Boston and San Francisco. Prior to that role, he served as a Managing Director for Roche Pharmaceuticals in Colombia and General Manager of Novartis Oncology for both Ecuador and Peru.
Message Presenter
Rohan Gandhi, PhD, VP, Medical Affairs, Cloudbreak Therapeutics
Rohan Gandhi currently serves as VP of Medical Affairs for Cloudbreak Therapeutics. He brings over 15 years of biotech experience. Rohan earned his PhD in Neuroscience and is a trained in vivo Pharmacologist.
Prior to joining Cloudbreak Therapeutics, he served as VP of Medical Affairs for Autobahn Therapeutics where he spearheaded the development and implementation of medical affairs strategies for novel products in adrenomyeloneuropathy (AMN), multiple Sclerosis and depression, with an emphasis and dedication to advancing scientific and medical education. Before joining Autobahn and Cloudbreak, he has worked within medical affairs, translational medicine and pharmacology.
Message PresenterWho Should Attend?
This webinar will appeal to professionals working in the following fields/having the following job titles:
- Medical affairs
- Commercial strategy
- Pharmaceutical Executives
- Market access and development
- Investors and Financial Analysts
What You Will Learn
In this webinar, attendees will:
- LEARN how to prioritize tactics that maximize value within constrained budgets, ensuring that every dollar spent contributes to building a strong foundation for future success
- UNDERSTAND how to drive company and scientific awareness thoughtfully in a crowded market
- GAIN direct access, actionable advice and best practices from industry experts who understand the challenges SMID companies are facing
Xtalks Partner
Syneos Health®
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. They translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together they share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. They support a diverse, equitable and inclusive culture.
To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account